WuXi Biologics Released a New cGMP Drug Product Manufacturing Facility to Support End-to-End Services for Diversified Modalities
Excerpt With further capacity and capability for drug product fill & finish, WuXi Biologics provides global customers with end-to-end integrated solutions for diversified modalities, including mRNA-LNP. Article Summary WuXi Biologics announced its new drug product (DP) facility, named DP8 – located in Hangzhou, China, has completed the first batch of GMP manufacturing. The DP8 facility […]
PharmaEssentia breaks ground on Hsinchu plant
Article Summary PharmaEssentia Corp (藥華醫藥), which provides drugs for a rare type of blood cancer, broke ground for a new factory in Hsinchu, which is scheduled to be completed in 2025. The plant is expected to boost the company’s annual production value by NT$40 billion (US$1.25 billion), executives from the firm said at the […]
GSK opens first high-potency facility in Singapore to produce drugs for cancer treatment
Excerpt GSK invested S$44m t in the new high potency manufacturing facility and laboratory further strengthening Jurong site capabilities to launch new products more quickly. This facility will manufacture a key ingredient for antibody drug conjugates (ADCs). Article Summary GSK officially opened its first high-potency manufacturing and test facility in Jurong, Singapore with the capability […]
BioNTech Expands Global Footprint by Acquiring GMP Manufacturing Site to Establish First mRNA Facility in Singapore
Excerpt BioNTech’s first mRNA manufacturing facility in Singapore is expected to be fully operational in late 2023 and will create regional manufacturing capacities in support of BioNTech’s growing pipeline of mRNA-based vaccines and therapeutics across Asia Pacific region for both clinical and commercial scale. Article Summary BioNTech announced its Singapore affiliate BioNTech Pharmaceuticals Asia Pacific […]
BioNTech and Australia’s State of Victoria Form Strategic Partnership to Establish mRNA Research Center and Manufacturing Facility
Excerpt BioNTech and Australia’s State of Victoria will establish an mRNA research and innovation center to strengthen translational research for innovative medicines from discovery to delivery. Article Summary State of Victoria in Australia and BioNTech SE have signed a Letter of Intent to collaborate on the research and development of potential mRNA-based vaccines and therapies. […]
Samsung Biologics unlocks additional capacity for production at its newest Plant 4
Excerpt Samsung Biologics has commenced the Plant 4 GMP operations this month within just 23 months since groundbreaking, delivering on Samsung Biologics commitment made in 2020. Article Summary Samsung Biologics, a leading contract development and manufacturing organization (CDMO), announced today that its Plant 4 – the world’s largest single bio manufacturing plant – has commenced […]
MSD Launches New Manufacturing Facilities In Singapore For Innovative Medicines And Vaccines As Part Of Up To Us$500 Million Multiyear Investment
Excerpt MSD’s newly commissioned secondary packaging and sterile filling facility will increase production of immunotherapy for cancer patients in Singapore and the Asia Pacific region. With fully automated and semi-automated packaging lines, it will significantly increase production of MSD’s cancer immunotherapy and vaccines. Article Summary MSD announced the opening of a new secondary packaging facility […]
Cytiva strengthens cell line development with CEVEC acquisition
Excerpt Cytiva acquisition of CEVEC Pharmaceuticals with 46 scientific experts based in Cologne, Germany will join the Cytiva team in the genomic medicine space. Cytiva customers will have immediate access to technologies that solve some of the greatest challenges in bringing gene therapies to patients. Article Summary Cytiva has acquired CEVEC Pharmaceuticals, a leading German […]
Otsuka and Lundbeck Announce U.S. FDA Acceptance of New Drug Application for Aripiprazole
Excerpt U.S. FDA accepts the NDA for Otsuka and Lundbeck codevelop aripiprazole 2-month, ready-to-use, long-acting injectable, a medication administered for the treatment of schizophrenia in adults and for maintenance monotherapy treatment of bipolar I disorder in adults Article Summary Otsuka America Pharmaceutical, Inc., (Otsuka) and H. Lundbeck A/S (Lundbeck) announce the U.S. Food and […]
Juniper Biologics Establishes Global Headquarters in Singapore
Excerpt Juniper Biologics’ continued expansion of its global operations and established global headquarters investment will support the growth and innovation of Singapore’s pharmaceutical sector. Article Summary Juniper Biologics, a science-led speciality healthcare company focused on commercializing novel therapies, announced the establishment of its Global Headquarters in Singapore, from where the Company will continue the expansion […]
European Commission approves Roche’s Vabysmo, the first bispecific antibody for the eye, for two leading causes of vision loss
Excerpt Roche’s Vabysmo Phase III data shows people with nAMD and DME who received treatments up to every four months achieved similar outcomes compared to receiving treatment every two months with aflibercept. Article Summary Vabysmo® (faricimab) developed by Roche was approved by the European Commission (EC) for the treatment of neovascular or ‘wet’ age-related […]
AbbVie announced positive results of clinical trials Phase 3 evaluating an NSAID treatment for active psoriatic arthritis
Excerpt AbbVie’s long-term data analyses of KEEPsAKE 1 and 2, Phase 3 trials evaluating SKYRIZI® (risankizumab, 150 mg) in adult patients with active psoriatic arthritis showed positive results and reduced symptoms over a 100 week period. Article Summary AbbVie announced new, long-term data analyses of KEEPsAKE 1 and 2, Phase 3 trials evaluating SKYRIZI® […]
